Article Information
History
- September 6, 2021.
Copyright
The copyright holder for this preprint is the author/funder, who has granted medRxiv a license to display the preprint in perpetuity. All rights reserved. No reuse allowed without permission.
Author Information
- Jeanne Tie1,2,3,4,*,
- Serigne N. Lo5,6,7,
- Joshua D. Cohen8,
- Yuxuan Wang8,
- Rachel Wong1,9,10,
- Jeremy Shapiro11,
- Sam Harris12,
- Adnan Khattak13,
- Matthew Burge14,
- Bert Vogelstein8 and
- Peter Gibbs1,2,4
- 1Division of Personalised Oncology, The Walter and Eliza Hall Institute of Medical Research, Melbourne, Australia
- 2Department of Medical Oncology, Western Health, Melbourne, Australia
- 3Department of Medical Oncology, Peter MacCallum Cancer Centre, Melbourne, Australia
- 4Faculty of Medicine, Dentistry and Health Sciences, University of Melbourne, Australia
- 5Melanoma Institute Australia, The University of Sydney, Australia
- 6Faculty of Medicine and Health, The University of Sydney, Sydney, Australia
- 7Institute for Research and Medical Consultations (IRMC), Imam Abdulrahman Bin Faisal University, Dammam, Kingdom of Saudi Arabia
- 8Ludwig Center and Howard Hughes Medical Institute, Sidney Kimmel Comprehensive Cancer Center, Johns Hopkins Medicine, Baltimore, USA
- 9Department of Medical Oncology, Eastern Health, Melbourne, Australia
- 10Eastern Health Clinical School, Faculty of Medicine, Nursing and Health Sciences, Monash University, Melbourne, Australia
- 11Cabrini Health, Melbourne, Australia
- 12Department of Medical Oncology, Bendigo Health, Melbourne, Australia
- 13Department of Medical Oncology, Fiona Stanley Hospital, Perth, Australia
- 14Department of Medical Oncology, Royal Brisbane and Women’s Hospital, Brisbane, Australia
- ↵*Corresponding author; email: jeanne.tie{at}petermac.org
Posted September 06, 2021.
Circulating Tumour DNA Analysis Informing Adjuvant Chemotherapy in Stage II Colon Cancer (DYNAMIC Trial): Statistical Analysis Plan
